INTRODUCTION

Selenium (Se) is an important micronutrient in human health. It is incorporated in 25
selenoproteins containing selenocysteine at their active center e.g.: glutathione peroxidase (GPX), iodothyronine deiodinases, selenoprotein P, thioredoxin reductase, selenoprotein S and other selenoproteins. Because the health effect of Se is U-shaped, toxic concentrations may be harmful. This is why Se supplementation may be beneficial only in people with low Se status. Dietary Se intake varies worldwide from 7 μg to 4990 μg per day. The mean value in Europe is 40 μg per day and in the USA 93 μg per day (in women) to 134 μg per day (in men). Nutritional products that are rich in selenium are: brazil nuts, offal, seafood, cereals and grains [1] [2] [3] [4] .
Cardiovascular diseases may be associated with oxidative stress as a consequence of insufficient antioxidant dietary intake and an improper balance between pro-oxidant and antioxidant enzymes, leading to an excess of reactive oxygen species [5] . It has been proven that low GPX activity can be used to identify patients at high cardiovascular risk [6, 7] . As Se levels correlate positively with enzymatic activity and protein levels of GPX, Se plasma analysis may be used for indirect oxidative stress assessment [8, 9] . Insufficiency of GPX and Se may exacerbate endothelial dysfunction, low-density lipoprotein cholesterol oxidation, atherosclerosis, cardiac sensitivity to ischemia and reperfusion, as well as impaired thyroid hormones conversion. These phenomena may contribute to heart failure (HF) development [9] [10] [11] [12] [13] .
A prospective epidemiological study conducted in Finland revealed that the Se concentration in serum is inversely related to the risk of myocardial infarction (MI) occurrence and cardiovascular death [14] . Another research conducted in New Zealand showed that decreased levels of Se in blood in cigarette smokers is a risk factor for coronary heart disease [15] . Se deficiency is mentioned in the current European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic HF as a nutritional cause of the disease [16] . Se deficiency is a possible risk factor for Keshan disease -endemic cardiomyopathy in seleniumpoor areas of China [17] . Even in selenium-rich areas, HF caused by Se deficiency may be a result of malnutrition occurring in patients with HIV, intestine diseases, parenteral nutrition or it might occur after bariatric surgery [18] [19] [20] .
Because selenoproteins (GPX and iodothyronine deiodinases) may compete for Se, oxidative stress causing Se deficiency may contribute to disturbances of thyroid hormones conversion.
These conditions alone and collectively may affect the cardiovascular system. Lifestyle, diet and smoking habits differ from country to country and may influence Se levels. To our knowledge, Se levels were not studied in the context of thyroid function in patients with cardiovascular diseases in Poland. The main purpose of the study was evaluation of Se levels in Polish patients with MI, HF and healthy volunteers in relation to thyroid hormones levels.
We also evaluated the clinical course of MI and HF in subgroups with normal or lowered Se concentrations.
METHODS
Study population
The study protocol (prospective cohort study) was approved by the Ethics Committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Declaration of Helsinki. From June 2015 to August 2017 we prospectively evaluated 113 consecutively hospitalized patients and 30 healthy volunteers who gave written informed consent and fulfilled the inclusion/exclusion criteria: a) Group MI consisted of patients with acute MI with ST elevation or non-ST elevation, treated with primary percutaneous coronary intervention [21] . Exclusion criteria were: previous HF, thyroid disease, treatment with amiodarone, glucocorticosteroids, propranolol), clinical evidence of severe systemic disease (inflammatory, autoimmune, neoplastic disease or chronic renal disease (estimated Glomerular Filtration Rate (eGFR) < 30 mL/min/1.73m
2 ).
b) Group HF consisted of patients with decompensation of HF with reduced ejection fraction (HFrEF) [16] . Exclusion criteria were: acute coronary syndrome, thyroid disease, treatment with amiodarone, glucocorticosteroids, propranolol), clinical evidence of severe systemic disease (inflammatory, autoimmune, neoplastic disease or chronic renal disease (eGFR < 30 mL/min/1.73m 2 ).
Patients received optimal guideline-directed medical treatment. 
Biochemical tests
Single blood samples were collected for thyroid profiles and Se in C group. Serial blood samples were collected in MI and HF groups. Creatinine levels (Jaffé Gen.2 method, rate blanked, compensated) and eGFR/CKD-EPI/ were assessed at admission.
Serum levels of high sensitivity troponin T (hsTnT), creatinine kinase MB (CK-MB) and creatinine kinase (CK) (ECLIA method) in group MI were measured at admission and every 6
hours during the first 24 hours. Normal values were: hsTnT (<0,014 ng/mL), CK-MB (0-24
Biochemical tests were performed with the use of Roche Diagnostics GmbH (Mannheim, Germany) kits. Full Blood Count was performed with the use of Sysmex Corporation (Kobe, Japan) kits.
Samples for selenium levels in serum were taken on the 3 rd day of hospitalization using the Vacutainer system. After collection, blood samples were left to clot for 30 minutes and were centrifuged afterwards (1300G, 12 minutes). Serum samples were frozen at -80°C (-112°F).
On the day of analysis, samples were centrifuged (5000G, 5 minutes). Analyses were carried out using inductively coupled plasma mass spectrometry. Se determination was performed on an inductively coupled plasma mass spectrometer NexION 350D (PerkinElmer, Shelton, USA). The spectrometer was equipped with a dynamic reaction cell operating with high purity methane. It was calibrated using an external calibration technique. Calibration standards were prepared from 10 µg/mL Multi-Element Calibration Standard 3. Correlation 
Study end-points
Major adverse cardiovascular events (MACE) in MI and HF groups included: resuscitated cardiac arrest, cardiovascular death, re-hospitalization for heart failure decompensation requiring intravenous diuretics and/or catecholamines, evidence of ventricular tachycardia, severe sinus bradycardia or atrioventricular blocks. 
RESULTS
Characteristics of MI and HF groups and comparison of subgroups according to Se concentration are presented in Table 1 and Table 2 . NT-proBNP, hsCRP, WBC, eGFR, TSH, fT3, fT4, the fT3/fT4 ratio as well as all remaining echocardiographic parameters.
We did not find more frequent occurrence of individual MACE (p>0.05 for each predefined end point) nor for the composite endpoint of all adverse events (p>0.05) in MI-A and HF-A subgroups in comparison to MI-B and HF-B subgroups.
Comparison of MI, HF and C groups is presented in Table 3 . There was no difference regarding age and sex. The studied groups differed with respect to BMI and blood pressure.
The prevalence of Se deficiency was present in the majority of participants from MI and HF groups. Conversely, Se deficiency was found in the minority of participants in the control group. In addition, Se levels were lower in both MI and HF groups in comparison to the controls (Table 3, Figure 1 ).
Differences existed between study groups in TSH, fT3, fT4 and the fT3/fT4 ratio (Table 3 , Figure 2 ). There were differences in evolution of fT3 levels and fT3/fT4 ratio in both MI and HF groups (Figure 3 ). There was also a dynamic change of TSH during the acute phase of MI and its normalization during a follow-up (Figure 3 ).
Correlation analysis between Se, TSH and TH is presented in Table 4 and Figure 4 . There were weak correlations between Se, fT3 and fT4. Moderate correlations were found between Se and fT3/fT4 ratio.
We did not find correlations between selenium and clinical variables such as: LVEF, hsT, CK, CKMB, NT-proBNP, creatinine, WBC, hsCRP.
DISCUSSION
Our research revealed that Se levels were significantly lowered in both patients with MI and Turkey demonstrated that both dilated idiopathic and ischemic cardiomyopathy were associated with lower Se levels [23] . Conversely, another study conducted by Ghaemian et al.
of northern Iran did not support these results [24] . Lower Se concentrations were previously found in patients with myocardial infarction [15, [25] [26] [27] . Discrepancies found in various studies might have been caused by differences in Se intake in distinctive geographical areas.
The Mediterranean diet in the northern Iran is rich in Se. This is possibly the reason why both HF patients and healthy controls in their study had high Se levels [22, 24] .
In our research we did not find correlations between Se and clinical variables reflecting disease severity. Previously, Se levels were found to be positively correlated with serum CK activity, serum myoglobin and maximum troponin levels [25, 28, 29] . Another research revealed that Se may play a role in the clinical severity of HF (assessed by peak exercise oxygen consumption) [22] , rather than in the degree of left ventricular dysfunction [22] [23] [24] .
However, the results are inconclusive because some previous researches found a positive correlation between Se and the LVEF in HF, and coronary artery disease [30] [31] [32] 28] .
Nevertheless, sample sizes of the above study groups were very limited.
The presented findings suggest that Se levels may be lowered in both acute and chronic cardiac disorders. Further studies are needed because it is not clear whether Se deficiency contributes to disease progression or a marker of its severity only. In addition, data about Se supplementation and its possible positive influence on clinical variables are very limited and not focused on Se alone; instead they consider many micronutrients taken together. It is also important that in studies of Se supplementation, baseline and target Se levels were not clearly defined, although it is known that Se overdosing may be harmful [33] [34] [35] .
There is growing evidence that oxidative stress and thyroid function are significant factors in HF development, while GPX correlate with Se. We sought to check the relationship between Se and thyroid hormones. We found only weak correlations between Se and thyroid hormone levels, while the correlation between Se and fT3/fT4 ratio was moderate. It would be of interest to investigate the causality of this relationship.
Our results showed differences in thyroid profiles between groups. Patients with MI and HF The low T3 syndrome and the decreased fT3/fT4 ratio was previously shown to be a prognostic predictor of death in patients with heart diseases [37, 38] . Our data indicate that there is a difference in T4 to T3 conversion between acute and chronic conditions.
Additionally, there was no difference in the fT3/fT4 ratio between the MI group and the control group on follow-up. However, a lowered fT3/fT4 ratio was still present in the HF group in comparison to the control group. The results suggest that changes of the fT3/fT4 ratio are more dynamic and transient in MI in comparison to the more chronic condition of HF.
Although we were able to find articles considering Se deficiency and thyroid hormones disturbances in HF and MI patients, there is a lack of studies involving both conditions together. Lima et al. did not find connections between Se and thyroid hormones and concluded that hypothyroidism is possibly linked with severity of HF but not micronutrients
[39]. However, in our research not only we demonstrated lowered Se levels and disturbed thyroid hormones in study groups, but we also found a correlation between them. Perhaps there is a dependence between these phenomena. In our opinion, further research focused on Se levels, selenium-dependent enzymes and their influence on the course of cardiovascular diseases, especially HF is needed.
CONCLUSIONS
Se levels in both acute MI and HF patients are lower when compared to healthy volunteers.
Se deficiency is very frequent in acute MI and both acute and chronic HF.
The correlation between Se and thyroid hormones was found to be weak to moderate.
Further research on Se deficiency in relation to oxidative stress markers and thyroid hormone conversion disturbances in cardiovascular diseases is needed, particularly in HF patients. The potential role of Se deficiency in the progression of HF should also be studied to verify if there is a background for possible benefits of Se supplementation.
STUDY LIMITATIONS
Enrolling patients and performing the research in the decompensated heart failure or acute MI with strict entry criteria is difficult. As a result, the sample size of the study was limited. We mainly sought to evaluate the selenium and thyroid status in both groups comparing to controls and the study sample was not calculated to perform hard end-points analysis. This is why the value of clinical events rate assessment is limited. The control group was selected to meet similar demographics as the study groups, however the BMI median in the control group was above the normal range and it is a disadvantage of our research. The study was intended to show a real-life group of patients with HF and MI. This is why we did not exclude smokers although smoking may influence the Se levels. For the same reason we did not exclude smokers from the control group to have it comparable. Table 2 . footnote: Depending on data distribution mean  SD or median (Q1;Q3) was given. Abbreviations: group HF -heart failure group; subgroup HF-A -heart failure subgroup with Se below normal values, subgroup HF-B -heart failure subgroup with normal Se values. Remaining abbreviations -see Table 1 . Table 3 . footnote: Depending on data distribution mean  SD or median (Q1;Q3) was given. Abbreviations: DBP -diastolic blood pressure; SBP -systolic blood pressure. Remaining abbreviations -see Table 1 / Figure 1 .  -p<0.05 between group MI and HF,  -p<0.05 between group MI and C,  -p<0.05 between group HF and C. Table 4 footnote: Abbreviations -see Table 1 legend. Figure 1 . Se plasma levels in MI and HF patients in comparison to controls. Medians
ACKNOWLEDGMENTS
FIGURES
